EUVIMEDEUVIMED entdecken
Crossref

Improved sensitivity and specificity for citrin deficiency using selected amino acids and acylcarnitines in the newborn screening

Jun Kido iD, Johannes Häberle, Toju Tanaka, Masayoshi Nagao, Yoichi Wada, Chikahiko Numakura, Ryosuke Bo, Hiromi Nyuzuki, Sumito Dateki, Shinsuke Maruyama, Kei Murayama, Shinichiro Yoshida und 1 weitere

Journal of Inherited Metabolic Disease · 2024

DOI: 10.1002/jimd.12673 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Inherited Metabolic Disease, 2024. Verfasst von Jun Kido und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan. Hauptthemen laut MEDLINE: Neonatal Screening, Citrullinemia, Carnitine, Citrulline. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Ministry of Health, Labour and Welfare, Japan Agency for Medical Research and Development, Ministry of Education, Culture, Sports, Science, and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Citrin deficiency is an autosomal recessive disorder caused by a defect of citrin resulting from mutations in the SLC25A13 gene. Intrahepatic cholestasis and various metabolic abnormalities, including hypoglycemia, galactosemia, citrullinemia, and hyperammonemia may be present in neonates or infants in the “neonatal intrahepatic cholestasis caused by citrin deficiency” (NICCD) form of the disease. Because at present, newborn screening (NBS) for citrin deficiency using citrulline levels in dried blood spots (DBS) can only detect some of the patients, we tried to develop a new evaluation system to more reliably detect newborns with citrin deficiency utilizing parameters already in place in present NBS methods. To achieve this goal, we re‐analyzed NBS profiles of amino acids and acylcarnitines in 96 NICCD patients, who were diagnosed through selective screening or positive family history. Hereby, we identified the combined evaluation of arginine (Arg), citrulline (Cit), isoleucine+leucine (Ile + Leu), tyrosine (Tyr), free carnitine (C0) / glutarylcarnitine (C5‐DC) ratio in DBS as potentially sensitive to diagnose citrin deficiency in pre‐symptomatic newborns. In particular, a scoring system using threshold levels for Arg (≥9 μmol/L), Cit (≥ 39 μmol/L), Ile + Leu (≥ 99 μmol/L), Tyr (≥ 96 μmol/L) and C0/C5‐DC ratio (≥327) was significantly effective to detect newborns who later developed NICCD, and could thus be implemented in existing NBS programs at no extra analytical costs whenever citrin deficiency is considered to become a novel target disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neonatal ScreeningCitrullinemiaCarnitineCitrullineDried Blood Spot TestingAmino AcidsHumansInfant, NewbornSensitivity and SpecificityMaleFemaleOrganic Anion TransportersMitochondrial Membrane Transport ProteinsMutationCalcium-Binding Proteins

Stichwörter der Autor:innen

NICCDargininecitrin deficiencycitrullinefree carnitinenewborn screeningtyrosine

Substanzen

CarnitineacylcarnitineCitrullineAmino AcidsSLC25A13 protein, humancitrinOrganic Anion TransportersMitochondrial Membrane Transport ProteinsCalcium-Binding Proteins

Autor:innen und Institutionen

  • Department of Pediatrics, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
  • Department of Pediatrics, Kumamoto University Hospital, Kumamoto, Japan.
  • University Children's Hospital Zurich and Children's Research Centre, Zurich, Switzerland.
  • Department of Pediatrics, National Hospital Organization Hokkaido Medical Center, Sapporo, Japan.
  • Department of Pediatrics, Tohoku University School of Medicine, Sendai, Japan.
  • Department of Pediatrics, Yamagata University School of Medicine, Yamagata, Japan.

ORCID-Profile: Jun Kido

Förderung

  • Ministry of Health, Labour and Welfare
  • Japan Agency for Medical Research and Development
  • Ministry of Education, Culture, Sports, Science, and Technology
  • Swiss National Science Foundation
  • Citrin Foundation
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Zitieren

APA

Kido, J., Häberle, J., Tanaka, T., Nagao, M., Wada, Y., Numakura, C., Bo, R., Nyuzuki, H., Dateki, S., Maruyama, S., Murayama, K., Yoshida, S., & Nakamura, K. (2024). Improved sensitivity and specificity for citrin deficiency using selected amino acids and acylcarnitines in the newborn screening. Journal of Inherited Metabolic Disease. https://doi.org/10.1002/jimd.12673

Vancouver

Kido J, Häberle J, Tanaka T, Nagao M, Wada Y, Numakura C, et al. Improved sensitivity and specificity for citrin deficiency using selected amino acids and acylcarnitines in the newborn screening. Journal of Inherited Metabolic Disease. 2024. doi:10.1002/jimd.12673

BibTeX
@article{Kido2024,
  author = {Kido, Jun and Häberle, Johannes and Tanaka, Toju and Nagao, Masayoshi and Wada, Yoichi and Numakura, Chikahiko and Bo, Ryosuke and Nyuzuki, Hiromi and Dateki, Sumito and Maruyama, Shinsuke and Murayama, Kei and Yoshida, Shinichiro and Nakamura, Kimitoshi},
  title = {Improved sensitivity and specificity for citrin deficiency using selected amino acids and acylcarnitines in the newborn screening},
  journal = {Journal of Inherited Metabolic Disease},
  year = {2024},
  doi = {10.1002/jimd.12673}
}
Kostenlos starten →